Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study

被引:21
|
作者
Yoneda, Y. [1 ]
Kunisada, T. [2 ]
Naka, N. [3 ]
Nishida, Y. [4 ]
Kawai, A. [5 ]
Morii, T. [6 ]
Takeda, K. [1 ]
Hasei, J. [1 ]
Yamakawa, Y. [1 ]
Ozaki, T. [1 ]
机构
[1] Okayama Univ, Dept Orthopaed Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
[2] Okayama Univ, Dept Med Mat Musculoskeletal Reconstruct, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan
[3] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan
[4] Nagoya Univ, Grad Sch & Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4648601, Japan
[5] Natl Canc Ctr, Dept Orthopaed Surg, Tokyo, Japan
[6] Kyorin Univ, Dept Orthopaed Surg, Tokyo, Japan
来源
EJSO | 2014年 / 40卷 / 01期
关键词
Elderly; Sarcoma; Soft tissue; Resection; CANCER CENTERS SARCOMA; LOCAL RECURRENCE; PROGNOSTIC-FACTORS; FRENCH FEDERATION; SURGICAL MARGINS; ADULT PATIENTS; HIGH-GRADE; EXTREMITY; METASTASIS; SURVIVAL;
D O I
10.1016/j.ejso.2013.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The surgical management of soft tissue sarcoma (STS) in elderly patients has only been addressed in a few studies. The objective of the current study was to assess surgical outcomes in patients with STS aged 70 years and older and the association of older age with the survival after complete resection. Methods: A retrospective analysis was conducted in 158 elderly patients with localized STS who visited 11 institutions participating in Japanese Musculoskeletal Oncology Group between 1995 and 2006 and were treated by surgical resection. Univariate and multivariate analyses were performed to identify prognostic factors. Results: Median follow-up period was 38 months. Histologically high-grade tumors were detected in 71% of the patients. Wide resection with adequate margins was performed in 66% of the cases. Systemic chemotherapy was performed in only 5 patients. Univariate analysis identified histological grade and gender as statistically significant prognostic factors for sarcoma-specific survival. Multivariate analysis did not identify significant prognostic factors for sarcoma-specific survival, although high grade sarcoma emerged as a potentially significant prognostic factor (P = 0.050). Local recurrence was detected in 19% of the patients. Multivariate analysis of local recurrence-free survival showed that tumor site and surgical margins were statistically significant prognostic factors. Conclusions: Older age was not identified as a prognostic factor for sarcoma-specific survival, which is not consistent with the findings of previous studies showing that older age was associated with decreased sarcoma-specific survival. Complete resection should be indicated and can lead to optimal treatment outcome for properly selected elderly patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [1] The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
    Nakamura, Tomoki
    Matsumine, Akihiko
    Kawai, Akira
    Araki, Nobuhito
    Goto, Takahiro
    Yonemoto, Tsukasa
    Sugiura, Hideshi
    Nishida, Yoshihiro
    Hiraga, Hiroaki
    Honoki, Kanya
    Yasuda, Taketoshi
    Boku, Shogen
    Sudo, Akihiro
    Ueda, Takafumi
    CANCER, 2016, 122 (09) : 1408 - 1416
  • [2] The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
    Tomoki Nakamura
    Satoshi Tsukushi
    Kunihiro Asanuma
    Hirohisa Katagiri
    Kunihiro Ikuta
    Akihito Nagano
    Eiji Kozawa
    Satoshi Yamada
    Yoji Shido
    Kenji Yamada
    Katsuhisa Kawanami
    Daisuke Ishimura
    Akihiro Sudo
    Yoshihiro Nishida
    Clinical & Experimental Metastasis, 2019, 36 : 343 - 350
  • [3] The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study
    Nakamura, Tomoki
    Tsukushi, Satoshi
    Asanuma, Kunihiro
    Katagiri, Hirohisa
    Ikuta, Kunihiro
    Nagano, Akihito
    Kozawa, Eiji
    Yamada, Satoshi
    Shido, Yoji
    Yamada, Kenji
    Kawanami, Katsuhisa
    Ishimura, Daisuke
    Sudo, Akihiro
    Nishida, Yoshihiro
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (04) : 343 - 350
  • [4] The clinical outcome of pazopanib treatment for soft tissue sarcomas: A Japanese Musculoskeletal Oncology Group study
    Matsumine, Akihiko
    Nakamura, Tomoki
    Kawai, Akira
    Araki, Nobuhito
    Goto, Takahiro
    Yonemoto, Tsukasa
    Sugiura, Hideshi
    Nishida, Yoshihiro
    Hiraga, Hiroaki
    Ueda, Takafumi
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study
    Kobayashi, Hiroshi
    Iwata, Shintaro
    Wakamatsu, Toru
    Hayakawa, Keiko
    Yonemoto, Tsukasa
    Wasa, Junji
    Oka, Hiroyuki
    Ueda, Takafumi
    Tanaka, Sakae
    CANCER, 2020, 126 (06) : 1253 - 1263
  • [6] Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients
    Lahat, G.
    Dhuka, A. R.
    Lahat, S.
    Lazar, A. J.
    Lewis, V. O.
    Lin, P. P.
    Feig, B.
    Cormier, J. N.
    Hunt, K. K.
    Pisters, P. W. T.
    Pollock, R. E.
    Lev, D.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2579 - 2586
  • [7] Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients
    G. Lahat
    A. R. Dhuka
    S. Lahat
    A. J. Lazar
    V. O. Lewis
    P. P. Lin
    B. Feig
    J. N. Cormier
    K. K. Hunt
    P. W. T. Pisters
    R. E. Pollock
    D. Lev
    Annals of Surgical Oncology, 2009, 16 : 2579 - 2586
  • [8] MANAGEMENT OF GYNECOLOGIC SOFT TISSUE SARCOMA AFTER COMPLETE RESECTION
    Ray-Coquard, I.
    Sunyach, M. P.
    Thiesse, P. H.
    Meeus, P.
    Cassier, P. H.
    Collard, O.
    Vaz, G.
    Ducimetiere, F.
    Blay, J. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan - The Japanese musculoskeletal Oncology Group cooperative study
    Obata, Hideto
    Ueda, Takafumi
    Kawai, Akira
    Ishii, Takeshi
    Ozaki, Toshifumi
    Abe, Satoshi
    Tanaka, Kazuhiro
    Tsuchiya, Hiroyuki
    Matsumine, Akihiko
    Yabe, Hiroo
    CANCER, 2007, 109 (04) : 767 - 775
  • [10] Clinical Outcome in Patients With High-grade Soft-tissue Sarcoma Receiving Prosthetic Replacement After Tumor Resection of the Lower Extremities: Tokai Musculoskeletal Oncology Consortium Study
    Nakamura, Tomoki
    Sakai, Tomohisa
    Tsukushi, Satoshi
    Kimura, Hiroaki
    Wasa, Junji
    Hosono, Kozo
    Izubuchi, Yuya
    Kozawa, Eiji
    Nagano, Akihito
    Asanuma, Kunihiro
    Sudo, Akihiro
    Nishida, Yoshihiro
    IN VIVO, 2023, 37 (06): : 2642 - 2647